.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Colorcon
Teva
US Army
Argus Health
Chinese Patent Office
Harvard Business School
Dow
Johnson and Johnson

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020961

« Back to Dashboard
NDA 020961 describes VITRAVENE PRESERVATIVE FREE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the VITRAVENE PRESERVATIVE FREE profile page.

The generic ingredient in VITRAVENE PRESERVATIVE FREE is fomivirsen sodium. Additional details are available on the fomivirsen sodium profile page.

Summary for NDA: 020961

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength6.6MG/ML
Approval Date:Aug 26, 1998TE:RLD:No

Expired Orange Book Patents for NDA: 020961

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Novartis
Fish and Richardson
QuintilesIMS
Citi
Federal Trade Commission
Daiichi Sankyo
Julphar
Covington
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot